132
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

In situ PEGylation of Bi nanoparticles prepared via pulsed Nd:YAG laser ablation in low molecular weight PEG: a potential X-ray CT imaging contrast agent

, &
Pages 420-427 | Received 11 Aug 2017, Accepted 12 Mar 2018, Published online: 22 Mar 2018
 

Abstract

Recent advances and studies have shown that inorganic nanomaterials based on heavy elements represent a new contrast agent which is highly appropriate for X-ray computed tomography (CT) in comparison with commercial Iohexol contrast agents which have several limitations, including short imaging time, rapid renal clearance and toxicity. In this contribution, elemental bismuth (Bi) nanoparticles with polyethylene glycol (PEG) coating are synthesised by pulsed Nd:YAG laser ablation of Bi target in PEGs with 400 and 600 g/mol molecular weight. The effect of PEG molecular weight as surface coating on colloidal stability and size distribution of Bi nanoparticles were investigated. It is found that by in situ surface modification during the ablation in low molecular PEG final particle size as well as average size decreases and colloidal stability increases. Moreover, X-ray attenuation of prepared PEG coated elemental Bi nanoparticles is higher than the commercial Iohexol contrast agent at the same concentration. Finally, the result demonstrates PEGylated Bi nanoparticles can be an appropriate low toxic X-ray contrast agent for the medical application.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.